Polycystic Kidney Disease (PKD) Study
November 17, 2014
ABOUT THE STUDY
FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
WHO CAN JOIN THE STUDY?
YOU MAY BE ELIGIBLE FOR THIS STUDY IF YOU:
• Are 18 to 70 years of age
• Have been diagnosed with ADPKD
Other eligibility criteria will apply.
Qualified volunteers will receive at no cost:
• Study medication
• Study-related care from a local doctor
• Reimbursement for your time and travel upto $1,960.00
Please call our office at 614-487-2560 or email us at email@example.com to schedule an appointment.